Ghosal Hematodiaphyseal Dysplasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Hemic and Lymphatic Diseases
|
Congenital Abnormality
|
2
|
6
|
0.720 |
None |
1.000 |
3 |
6
|
2008 |
2019 |
Thromboxane synthetase deficiency
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
2
|
2
|
0.600 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
GHOSAL HEMATODIAPHYSEAL SYNDROME
|
disease |
|
Finding
|
1
|
3
|
0.400 |
limited |
|
0 |
3
|
|
|
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.310 |
None |
< 0.001 |
1 |
1
|
2009 |
2009 |
Drug Allergy
|
group |
Immune System Diseases; Chemically-Induced Disorders
|
Pathologic Function
|
37
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.210 |
None |
1.000 |
2 |
|
2001 |
2018 |
Reperfusion Injury
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Injury or Poisoning
|
300
|
|
0.200 |
None |
1.000 |
2 |
|
1996 |
2004 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.200 |
None |
1.000 |
2 |
|
1997 |
2005 |
Pancreatitis, Acute Necrotizing
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
62
|
1
|
0.200 |
None |
1.000 |
1 |
|
1998 |
1998 |
Endotoxemia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
401
|
5
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hydronephrosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
253
|
18
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Pulmonary Embolism
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Pathologic Function
|
93
|
16
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Alcoholic Liver Diseases
|
group |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
195
|
20
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Brain Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
114
|
11
|
0.200 |
None |
1.000 |
1 |
|
2003 |
2003 |
Thrombosis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
98
|
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Membranous glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
197
|
33
|
0.200 |
None |
1.000 |
1 |
|
1996 |
1996 |
Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
391
|
7
|
0.200 |
None |
1.000 |
1 |
|
1999 |
1999 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
White Blood Cell Count procedure
|
phenotype |
|
Laboratory Procedure
|
681
|
1322
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
4
|
2012 |
2012 |